Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Clofazimine may be effective for treating ashy dermatosis.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Tofacitinib may help treat hair loss in children with alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Tofacitinib is effective and safe for treating alopecia areata.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib may help regrow hair in alopecia areata patients.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.